Martin Forrest Healthcare News

This is selected healthcare news for Martin Forrest, which is filed under People. There are 20 news items for this page. A press release filter page is also available for Martin Forrest.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
7/29/2020 Five Prime Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference | Business & Finance | heraldchronicle.com
... please visit https://www.fiveprime.com . Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20200729006073/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH SOURCE: Five Prime ...
Business Wire
4/22/2020 Five Prime Therapeutics Changes 2020 Annual Meeting to Virtual Format | Business & Finance | heraldchronicle.com
... LinkedIn , Twitter and Facebook . Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20200422005924/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ONCOLOGY ...
Business Wire
3/13/2020 Five Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study in the Journal of Clinical Oncology | Business & Finance | heraldchronicle.com
... new information becomes available. Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20200313005074/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ONCOLOGY ...
Business Wire
12/30/2019 Five Prime Therapeutics to Participate in the 38th Annual J.P. Morgan Healthcare Conference
... has promising product candidates in clinical and preclinical development. For more information, please visit www.fiveprime.com . Source: Five Prime Therapeutics, Inc. Contacts Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. 415-365-5625 [email protected] ...
Business Wire
12/30/2019 Five Prime Therapeutics to Participate in the 38th Annual J.P. Morgan Healthcare Conference | Business & Finance | manchestertimes.com
... information, please visit www.fiveprime.com . Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20191230005080/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ONCOLOGY ...
Business Wire
11/9/2019 Five Prime Therapeutics Presents Initial Safety Data from the Phase 1 Trial of FPT155 at the Society for Immunotherapy of Cancer Annual Meeting
... statements contained herein to reflect any change in expectations, even as new information becomes available. Source: Five Prime Therapeutics, Inc. Contacts Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. 415-365-5625 [email protected] ...
Business Wire
11/9/2019 Five Prime Therapeutics Presents Initial Safety Data from the Phase 1 Trial of FPT155 at the Society for Immunotherapy of Cancer Annual Meeting
... new information becomes available. Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20191109005015/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA MARYLAND INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ...
Business Wire
10/10/2019 Five Prime Announces Restructuring | Business & Finance | manchestertimes.com
... change in expectations, even as new information becomes available. View source version on businesswire.com : https://www.businesswire.com/news/home/20191010005744/en/ CONTACT: Media and Investor Contact Martin Forrest, Vice President, Investor Relations & Corporate Communications 415-365-5625 KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL ONCOLOGY HEALTH CLINICAL TRIALS OTHER HEALTH ...
Business Wire
9/30/2019 Five Prime Therapeutics Presents Updated Data From the Phase 1a/1b Trial of FPA150 at the European Society for Medical Oncology 2019 Congress
... statements contained herein to reflect any change in expectations, even as new information becomes available. Source: Five Prime Therapeutics, Inc. Contacts Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. 415-365-5625 [email protected] ...
Business Wire
9/30/2019 Five Prime Therapeutics Presents Updated Data From the Phase 1a/1b Trial of FPA150 at the European Society for Medical Oncology 2019 Congress | Business & Finance | heraldchronicle.com
... new information becomes available. Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20190930005202/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: ONCOLOGY HEALTH CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY ...
Business Wire
8/23/2019 Five Prime Therapeutics to Present at Upcoming Healthcare Conference
... in clinical and preclinical development. For more information, please visit www.fiveprime.com or follow us on LinkedIn , Twitter and Facebook . Source: Five Prime Therapeutics, Inc. Contacts Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. 415-365-5625 [email protected] ...
Business Wire
8/22/2019 Five Prime Therapeutics to Present at Upcoming Healthcare Conference | Business & Finance | heraldchronicle.com
... or follow us on LinkedIn , Twitter and Facebook . Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20190822005723/en/ CONTACT: Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: ONCOLOGY HEALTH CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY ...
Business Wire
8/10/2019 Five Prime Therapeutics, Inc. (FPRX) Aron Knickerbocker
Five Prime Therapeutics, Inc. (NASDAQ: FPRX ) Q2 August 00, 2019 04:30 PM Martin Forrest - VP of IR & Corporate Communications Aron Knickerbocker - CEO Dr. Helen Collins - CMO David Smith - CFO Jonathan Chang - SVB Leerink Timor Vanicus - Raymond James Charles Xu - Guggenheim Securities Chris Shibutani - Cowen Tony Butler - Roth Capital Partners Maryana ...
Seeking Alpha
8/1/2019 Five Prime Therapeutics to Present at Upcoming Healthcare Conference
... development. For more information, please visit www.fiveprime.com or follow us on LinkedIn , Twitter and Facebook . Source: Five Prime Therapeutics, Inc. Contacts Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. 415-365-5625 [email protected] ...
Business Wire
8/1/2019 Five Prime Therapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call
... LinkedIn , Twitter and Facebook . Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20190731006122/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: ONCOLOGY HEALTH CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY ...
Business Wire
5/10/2019 Five Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on Q1 2019 Results - Earnings Call Transcript
Five Prime Therapeutics, Inc. (NASDAQ: FPRX ) Q1 2019 Earnings Conference Call May 2, 2019 4:30 AM ET Company Participants Martin Forrest - VP of IR & Corporate Communications Aron Knickerbocker - President and CEO Bryan Irving - Chief Scientific Officer David Smith - Chief Financial Officer Dr. Helen Collins - Chief Medical Officer Conference Call Participants ...
Seeking Alpha
5/9/2019 Five Prime Therapeutics (FPRX) Q1 2019 Earnings Call Transcript
... Therapeutics first-quarter 2019 earnings call. As a reminder, this conference call is being recorded. I'd like now to introduce your host for today's conference, Martin Forrest, vice president, investor relations and corporate communications. You may begin your conference. Martin Forrest -- Vice President, Investor Relations and Corporate Communications Thank you ...
Yahoo News